Kenvue Inc.

10-K & 10-Q Filings

Kenvue Inc. is a global pure-play consumer health company with $15.4 billion in net sales in 2023. Its purpose is to realize the extraordinary power of everyday care. The company operates through three reportable business segments: Self Care, Skin Health and Beauty, and Essential Health. Kenvue's brand portfolio includes iconic, trusted brands such as Tylenol, Neutrogena, Listerine, Johnson's, and BAND-AID. The company's digital-first approach to marketing allows it to reach high-value audiences efficiently and evaluate the impact of media investments through data science and analytics. Kenvue's R&D organization combines deep scientific expertise and engagement with healthcare professionals to create innovative products. The company's global and balanced manufacturing footprint provides flexibility and optimizes capital allocation. Kenvue's website is investors.kenvue.com, and its ticker symbol is "KVUE" on the New York Stock Exchange.

12 mos ending Dec 31, 2023Revenue (+)
$15444.00
Cost of Revenue (-)
$6801.00
Gross Profit (+)
$8643.00
Selling, General & Administrative (-)
$6141.00
Operating Expenses (-)
$6131.00
Costs & Expenses (Total) (-)
$12932.00
Operating Income/Loss (+)
$2512.00
Non-operating Income/Expense (+)
$-72.00
Interest Expense (-)
$250.00
Earnings before Tax (+)
$2190.00
Tax Expense (-)
$526.00
Income/Loss (Continuing Operations) (+)
$1664.00
Net Income/Loss (+)
$1664.00
Net Income/Loss (Common) (+)
$1664.00
EPS (Basic)
$0.90
EPS (Diluted)
$0.90
Weighted Avg Shares (Basic)
1846.13
Weighted Avg Shares (Diluted)
1850.33
Cash
$1382.00
Receivables
$2073.00
Inventory
$1851.00
Prepaid Expenses (Current)
$567.00
Other Assets (Current)
$265.00
Assets (Current)
$6138.00
Property, Plant & Equipment (Net)
$2042.00
Goodwill & Intangibles
$18890.00
Other Assets
$781.00
Assets (Non-current)
$21713.00
Assets (Total)
$27851.00
Accounts Payable
$3945.00
Debt (Current)
$599.00
Other Liabilities (Current)
$937.00
Liabilities (Current)
$5481.00
Debt (Non-current)
$7687.00
Other Liabilities
$3472.00
Liabilities (Non-current)
$11159.00
Liabilities (Total)
$16640.00
Treasury Stock
$7.00
Retained Earnings
$429.00
AOCI
$-5377.00
Shareholder's Equity
$11211.00
Liabilities & Equity
$27851.00
Net Income/Loss
$1664.00
Depreciation & Amortization
$627.00
Increase/Decrease in Working Capital
$-797.00
Share-based Compensation
$188.00
Adjustments to Reconcile Net Income
$1504.00
Net Cash (Operating)
$3168.00
Capital Expenditure
$469.00
Net Cash (Investing)
$-488.00
Increase/Decrease in Debt
$8246.00
Increase/Decrease in Equity
$4241.00
Interest Expenses
$224.00
Dividends Paid
$766.00
Net Cash (Financing)
$-2527.00
Cash Taxes Paid
$699.00
Effect of Exchange Rate
$-2.00
Increase/Decrease in Cash
$151.00
Cash (Beginning)
$1231.00
Cash (Ending)
$1382.00
NOPAT
$1710.22
Gross Margin %
55.96%
Operating Margin %
16.27%
NOPAT Margin %
11.07%
Net Margin %
10.77%
Tax Rate %
31.92%
ROA
6.14%
ROE
15.25%
ROIC
7.64%
Asset Turnover
0.55
Inventory Turnover
3.67
Equity Multiplier
2.48
Current Ratio
1.12
Quick Ratio
0.63
Debt/Equity Ratio
0.74
Interest Coverage Ratio
11.21
Working Capital/Sales
0.09
Dividend Payout Ratio %
44.79%
Total Payout
$-11497.00
Payout Ratio %
-672.25%